Israeli-based Kanabo Research could become the first cannabis firm to list on the main market of the London Stock Exchange.
The company, which has developed a vaporiser for the inhalation of medical cannabis, is planning to list through a reverse takeover by cash shell Spinnaker Opportunities.
Spinnaker has signed a head of terms to buy Kanabo and the deal is waiting on UK approval.
Chief executive Avihu Tamir sat down with Proactive’s Andrew Scott to talk about the deal and Kanabo's move towards the commercialisation of its VapePod device.

viewKanabo Research
Kanabo Research sets sights on London listing
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
FOR OUR FULL DISCLAIMER CLICK HEREMost read
Tech
Google’s co-founders step down from CEO and president role at parent Alphabet
6 days, 5 hours ago
Mining
Base, Bluejay and Savannah all set to benefit from increased mineral sands...
6 days, 4 hours ago
Tech
VR Education higher as it partners with Deutsche Telekom and Qualcomm for...
6 days, 2 hours ago